These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Remission in rheumatoid arthritis: wishful thinking or clinical reality? Sesin CA; Bingham CO Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659 [TBL] [Abstract][Full Text] [Related]
5. The measure of our measures. Harth M; Pope J Rheumatology (Oxford); 2004 Dec; 43(12):1465-7. PubMed ID: 15479755 [No Abstract] [Full Text] [Related]
6. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413 [TBL] [Abstract][Full Text] [Related]
7. Achieving tight control in rheumatoid arthritis. van Hulst LT; Hulscher ME; van Riel PL Rheumatology (Oxford); 2011 Oct; 50(10):1729-31. PubMed ID: 21933791 [No Abstract] [Full Text] [Related]
8. Performance of a rheumatoid arthritis records-based index of severity. Ting G; Schneeweiss S; Katz JN; Weinblatt ME; Cabral D; Scranton RE; Solomon DH J Rheumatol; 2005 Sep; 32(9):1679-87. PubMed ID: 16142860 [TBL] [Abstract][Full Text] [Related]
9. A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up. Verstappen SM; van Albada-Kuipers GA; Bijlsma JW; Blaauw AA; Schenk Y; Haanen HC; Jacobs JW; Ann Rheum Dis; 2005 Jan; 64(1):38-43. PubMed ID: 15130899 [TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of synovial arthritis]. Duodecim; 2004; 120(7):833-4. PubMed ID: 15154303 [No Abstract] [Full Text] [Related]
11. Rheumatoid arthritis: time for trials of therapeutic targets. Edmonds J; Lassere M J Rheumatol; 2002 Oct; 29(10):2041-4. PubMed ID: 12375309 [No Abstract] [Full Text] [Related]
15. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis. Wolfe F; Rasker JJ; Boers M; Wells GA; Michaud K Arthritis Rheum; 2007 Aug; 57(6):935-42. PubMed ID: 17665487 [TBL] [Abstract][Full Text] [Related]
16. Remission by composite scores in rheumatoid arthritis: are ankles and feet important? Kapral T; Dernoschnig F; Machold KP; Stamm T; Schoels M; Smolen JS; Aletaha D Arthritis Res Ther; 2007; 9(4):R72. PubMed ID: 17662115 [TBL] [Abstract][Full Text] [Related]
17. A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis. Gardiner PV; Bell AL; Taggart AJ; Wright G; Kee F; Smyth A; McKane R; Lee J; Rooney ME; Whitehead E Ann Rheum Dis; 2005 Mar; 64(3):506-7. PubMed ID: 15708909 [No Abstract] [Full Text] [Related]
18. Remission by imaging in rheumatoid arthritis: should this be the ultimate goal? van der Heijde D Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i89-92. PubMed ID: 22460147 [TBL] [Abstract][Full Text] [Related]
19. Assessing remission in clinical practice. Mierau M; Schoels M; Gonda G; Fuchs J; Aletaha D; Smolen JS Rheumatology (Oxford); 2007 Jun; 46(6):975-9. PubMed ID: 17341506 [TBL] [Abstract][Full Text] [Related]
20. Defining remission in rheumatoid arthritis: what is it? Does it matter? Paulus HE J Rheumatol; 2004 Jan; 31(1):1-4. PubMed ID: 14705208 [No Abstract] [Full Text] [Related] [Next] [New Search]